Your browser doesn't support javascript.
loading
Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis.
Kim, Min Seo; Song, Minku; Kim, Beomsu; Shim, Injeong; Kim, Dan Say; Natarajan, Pradeep; Do, Ron; Won, Hong-Hee.
Afiliación
  • Kim MS; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Song M; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim B; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Shim I; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim DS; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Natarajan P; Medical and Population Genetics and Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, MA, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Do R; The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Won HH; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea; Samsung Genome Institute, Samsung Medical Center, Seoul, Republic of Korea. Electronic address: wonhh@skku.edu.
Cell Rep Med ; 4(9): 101112, 2023 09 19.
Article en En | MEDLINE | ID: mdl-37582372

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dislipidemias / Proproteína Convertasa 9 Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dislipidemias / Proproteína Convertasa 9 Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos